US 8,147,866 B2
Transmucosal delivery devices with enhanced uptake
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

US 8,147,866 B2
Transmucosal delivery devices with enhanced uptake
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Johann Richter
Art Unit:
1616 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
Inventors:
Andrew Finn; Niraj Vasisht
Priority:
07/21/06
Filed:
07/15/11
Granted:
04/03/12
Expiration:
07/21/26
Abstract
The present invention provides methods for enhancing transmucosal uptake of a medicament, e.g., fentanyl or buprenorphine, to a subject and related devices. The method includes administering to a subject a transmucosal drug delivery device comprising the medicament. Also provided are devices suitable for transmucosal administration of a medicament to a subject and methods of their administration and use. The devices include a medicament disposed in a mucoadhesive polymeric diffusion environment and a barrier environment.
Cooperative Patent Classification (CPC)
A61A61P25/00A61K31/4468A61P

Analytics

Cases

Patent Assignments

Citations